Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases
Journal:
Current Drug Targets
Volume:
9
Page:
626-640
Author(s):
Fumio Sakane, Shin-ichi Imai, Masahiro Kai, Satoshi Yasuda and Hideo Kanoh
Targeting SphK1 as a New Strategy against Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
662-673
Author(s):
Dai Shida, Kazuaki Takabe, Dmitri Kapitonov, Sheldon Milstien and Sarah Spiegel
Therapeutic Potential of Autotaxin/Lysophospholipase D Inhibitors
Journal:
Current Drug Targets
Volume:
9
Page:
698-708
Author(s):
Lorenzo Federico, Zehra Pamuklar, Susan S. Smyth and Andrew J. Morris
Protein Kinase CK2 in Human Diseases
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1870-1886
Author(s):
Barbara Guerra and Olaf-Georg Issinger
Laminin-332-Integrin Interaction: A Target For Cancer Therapy?
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1968-1975
Author(s):
Daisuke Tsuruta, Hiromi Kobayashi, Hisayoshi Imanishi, Koji Sugawara, Masamitsu Ishii and Jonathan C.R. Jones
The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs
Journal:
Current Pharmaceutical Biotechnology
Volume:
9
Page:
253-260
Author(s):
Tracey J. Brown
Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Journal:
Current Pharmaceutical Biotechnology
Volume:
9
Page:
325-336
Author(s):
Michal Sabisz and Andrzej Skladanowski
The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
227-234
Author(s):
Arun Rajan and Ajeet Gajra
The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2140-2158
Author(s):
X. Lu, D. Lu, M. F. Scully and V. V. Kakkar
Adhesion Molecules in Lung Cancer: Implications in the Pathogenesis and Management
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2173-2183
Author(s):
Kostas N. Syrigos, Nikos Katirtzoglou, Elias Kotteas and Kevin Harrington